Advanced Search

Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
F 18.75 -1.83% -0.35
ODT closed down 1.29 percent on Tuesday, March 2, 2021, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ODT trend table...
Date Alert Name Type % Chg
NR7 Range Contraction -1.83%
Lower Bollinger Band Walk Weakness -1.83%
Wide Bands Range Expansion -1.83%
Oversold Stochastic Weakness -1.83%
Fell Below 50 DMA Bearish -3.10%
MACD Bearish Centerline Cross Bearish -3.10%
180 Bearish Setup Bearish Swing Setup -3.10%
Lower Bollinger Band Walk Weakness -3.10%
Multiple of Ten Bearish Other -3.10%
Outside Day Range Expansion -3.10%
Older End-of-Day Signals for ODT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 5 hours ago
60 Minute Opening Range Breakout about 5 hours ago
Up 1% about 6 hours ago
Down 3% about 7 hours ago
Down 2 % about 7 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pharmaceutical Spotlight Innovation Urbandale

Is ODT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 23 Odonate Therapeutics EPS misses by $0.12
Feb 23 Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020
Feb 1 Revisiting Odonate Therapeutics
Jan 10 Odonate: A Simple Story Of An Oral Taxane
Jan 8 Odonate Therapeutics: Likely Tesetaxel Approval Means Company Is Undervalued
Jan 2 Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More
Jan 2 3 Beaten-Down Stocks Insiders Scooped Up as 2020 Ended
Jan 2 Craig Johnson Is The Independent Director of Odonate Therapeutics, Inc. (NASDAQ:ODT) And Just Spent US$51k On Shares
Dec 29 12 Health Care Stocks Moving In Tuesday's After-Market Session
Dec 28 70 Biggest Movers From Thursday
See more ODT news...

Indicators

Indicator Value
52 Week High 46.4999
52 Week Low 12.56
Average Volume 486,103
200-Day Moving Average 24.36
50-Day Moving Average 20.98
20-Day Moving Average 23.41
10-Day Moving Average 21.85
Average True Range 1.78
ADX 32.52
+DI 15.25
-DI 23.76
Chandelier Exit (Long, 3 ATRs ) 23.06
Chandelier Exit (Short, 3 ATRs ) 24.15
Upper Bollinger Band 28.10
Lower Bollinger Band 18.73
Percent B (%b) 0.04
BandWidth 40.04
MACD Line -0.42
MACD Signal Line 0.40
MACD Histogram -0.8203
Fundamentals Value
Market Cap 735.94 Million
Num Shares 38.5 Million
EPS -4.46
Price-to-Earnings (P/E) Ratio -4.28
Price-to-Sales 0.00
Price-to-Book 3.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.77
Resistance 3 (R3) 20.86 20.39 20.49
Resistance 2 (R2) 20.39 19.96 20.34 20.40
Resistance 1 (R1) 19.74 19.70 19.51 19.66 20.31
Pivot Point 19.27 19.27 19.15 19.23 19.27
Support 1 (S1) 18.63 18.85 18.39 18.54 17.89
Support 2 (S2) 18.16 18.58 18.11 17.80
Support 3 (S3) 17.51 18.16 17.71
Support 4 (S4) 17.43